
The FlightBridgeED Podcast MDCAST: The Stubborn Lethality of Cardiogenic Shock
May 19, 2026
A deep dive into why cardiogenic shock still carries high mortality and how changing patient populations drive rising cases. The SCAI A–E framework is highlighted as a tool to spot severity early. Practical transport-focused topics include MAP support, oxygenation strategies, volume and inotrope decisions, optimizing mechanical support, and the logistics of fast, safe transfers to specialized centers.
AI Snips
Chapters
Transcript
Episode notes
Cardiogenic Shock Mortality Has Not Improved
- Cardiogenic shock mortality has remained stubbornly high (~30–40%) despite major improvements in ACS care.
- Improvements in PCI and CCUs reduced MI deaths, but once patients develop cardiogenic shock outcomes have not improved substantially over decades.
More Survivors Now Present With Late Heart Failure
- Cardiogenic shock is becoming more common, driven largely by survivors of prior MIs living longer and later developing heart failure.
- These patients are more medically complex with comorbid kidney disease, prior strokes, and infections that worsen shock outcomes.
Use SCAI A–E Stages For Clear Communication
- Use the SCAI A–E shock stages to view cardiogenic shock as a spectrum and communicate severity early.
- Stage A at-risk through E extremis map to exam, lactate, MAP, and organ dysfunction to guide escalation and referrals.
